Methods used to assess pulmonary deposition and absorption of drugs

被引:49
作者
Mobley, C [1 ]
Hochhaus, G
机构
[1] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
关键词
D O I
10.1016/S1359-6446(01)01691-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The assessment of pulmonary drug absorption and deposition is becoming increasingly important in drug development. Absorption information can be used to maximize pulmonary selectivity, to screen drug candidates and to help evaluate the bioequivalence of generic inhalation products. Several methods are available to investigate pulmonary drug absorption and deposition, ranging from in vitro experiments to in vivo pharmacokinetic and pharmacodynamic analyses. In combination, these methods can indicate the fate of an inhaled drug.
引用
收藏
页码:367 / 375
页数:11
相关论文
共 64 条
[1]   A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration [J].
Argenti, D ;
Shah, B ;
Heald, D .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (07) :695-702
[2]  
BARTH J, 1989, ATEMWEG LUNGENKRANK, V15, P412
[3]   DUAL PATHWAY CLEARANCE OF TC-99M-DTPA FROM THE BRONCHIAL-MUCOSA [J].
BENNETT, WD ;
ILOWITE, JS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (05) :1132-1138
[4]  
Berridge MS, 2000, J NUCL MED, V41, P1603
[5]   A METHOD FOR DETERMINATION OF THE ABSOLUTE PULMONARY BIOAVAILABILITY OF INHALED DRUGS - TERBUTALINE [J].
BORGSTROM, L ;
NILSSON, M .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1068-1070
[7]  
Brattsand R., 1997, INHALED GLUCOCORTICO, P351
[8]   ISOLATED PERFUSED RABBIT LUNG AS A MODEL FOR INTRAVASCULAR AND INTRA-BRONCHIAL ADMINISTRATION OF BRONCHODILATOR DRUGS .2. ISOPROTERENOL PRODRUGS [J].
BRAZZELL, RK ;
KOSTENBAUDER, HB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (11) :1274-1281
[9]   Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler®, Diskus® and metered-dose inhaler in healthy volunteers [J].
Brindley, C ;
Falcoz, C ;
Mackie, AE ;
Bye, A .
CLINICAL PHARMACOKINETICS, 2000, 39 (Suppl 1) :1-8